Dystrobrevin alpha (DTNA) Antibody

Scientific Overview

This antibody supports experimental designs that examine Dystrobrevin alpha (DTNA) with interpretable controls and clear contrasts. Dystrobrevin alpha is a structural protein that interfaces with actin, microtubules, or associated adaptors. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

In some datasets and protocols, it is referenced by the gene symbol DTNA.

Research Relevance

Drug perturbations that affect polymerization or contractility can shift distribution and complex formation. Time course design can be decisive when regulation is transient or compartment dependent.

Since many cellular processes are coupled, measured differences can reflect both direct regulation and indirect effects from broader state changes.

When building a narrative around the target, it helps to track:

• remodeling after perturbation of polymerization or contractility
• differences across cell density or substrate stiffness
• association with junctional complexes or focal adhesions

Application-Specific Context

When assay conditions are still being tuned, a regular-format antibody supports stepwise adjustment of buffers and incubation steps. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. Align controls to the expected direction of change to support confident interpretation.

For challenging targets, pairing Dystrobrevin alpha measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

Integrate the regular format version into your design so Dystrobrevin alpha (DTNA) signals can be interpreted alongside matched controls.